Results 81 to 90 of about 13,816 (168)

Multidistrict invasive <i>Candida glabrata</i> infection successfully treated with echinocandin and liposomal amphotericin B combination therapy: a case report and therapeutic perspective. [PDF]

Front Med (Lausanne)
Caracciolo M, D'Aleo F, Stagno MF, Papola C, Pellicano S, Nicolò GM, Caracciolo SA, Ripepi A, Pellicano N, Scopelliti C, Principe L, La Scala S.   +11 more
europepmc   +1 more source

Liposomal amphotericin B prophylaxis in paediatrics: a systematic review. [PDF]

J Antimicrob Chemother
Thorley EV, Hatch J, Li M, Mashida SN, Castagnola E, Mesini A, Lehrnbecher T, Groll AH, Warris A, Ferreras-Antolin L.   +9 more
europepmc   +1 more source

Synergistic eradication of <i>Candida albicans</i> prosthetic valve endocarditis with liposomal amphotericin B and high-dose caspofungin: a case report. [PDF]

Front Med (Lausanne)
Feng Q, Huang L, Luo H, Peng X, Zhang S.
europepmc   +1 more source

Successful Treatment of Mucormycosis and Azole-Resistant Aspergillus Coinfection in a Diabetic Patient: A Case Report

Infection and Drug Resistance
Tingting Zhao,1 Yuan Fang,1 Qiuhui Wu,2 Minke Shi,3 Yueyan Ni,1 Ruyi Zou,1 Mengying Liu,1 Weiwei Wu,4 Xin Su1 1Department of Respiratory and Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School,
Zhao T, Fang Y, Wu Q, Shi M, Ni Y, Zou R, Liu M, Wu W, Su X   +8 more
doaj  

Successful Treatment of Refractory <i>Candida auris</i> Ventriculitis With Intraventricular Liposomal Amphotericin B. [PDF]

Clin Case Rep
Vu CA, Ladd K, Ayoade FO.
europepmc   +1 more source

Efficacy of Liposomal Amphotericin B in Treating Pulmonary <i>Aspergillus flavus</i> Infection in Nonneutropenic Adults: Cases Report and Literature Review. [PDF]

Clin Case Rep
Chen X, Wang L, Li J, Zhang Y, Liu C, Yang J, Shi J, Liang S.   +7 more
europepmc   +1 more source

Comparative effectiveness of echinocandins and liposomal amphotericin B for fluconazole-resistant <i>Candida parapsilosis</i> bloodstream infections. [PDF]

Antimicrob Agents Chemother
Vena A, Bartalucci C, Muccio M, Tiseo G, Muñoz P, Cesaretti M, Di Pilato V, Marchese A, Barbieri R, Forniti A, Giacobbe DR, Limongelli A, Lupetti A, Mikulska M, Salmanton-García J, Soriano Martín A, Taramasso L, Valerio M, Escribano P, Guinea J, Bouza E, Falcone M, Bassetti M, ESCMID Fungal Infection Study Group (EFISG).   +23 more
europepmc   +1 more source

Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing. [PDF]

Clin Pharmacol Ther
Chu WY, Singh OP, Sundar S, Mondal D, Pandey K, Das P, Roseboom IC, Raja S, Torres A, Carrillo E, Huitema ADR, Alves F, Dorlo TPC.   +12 more
europepmc   +1 more source

Liposomal amphotericin B and complement activation-related pseudoallergy (CARPA). [PDF]

Antimicrob Agents Chemother
Thompson GR, Sani GM, Donnelley MA, Figueroa JK, Ciuffetelli R, Trigg K, Arredondo J, Koff A, Nearing M, Loque IC, Bays DJ, Dandekar S.   +11 more
europepmc   +1 more source

Comparative study of liposomal amphotericin B, posaconazole, and micafungin for primary antifungal prophylaxis in pediatric patients with acute leukemia. [PDF]

J Cancer Res Clin Oncol
Gottschlich AS, Ernst J, Milde T, Gruhn B.   +3 more
europepmc   +1 more source